期刊文献+

白藜芦醇在急性肾损伤中研究的进展

Research Progress of Resveratrol in Acute Kidney Injury
下载PDF
导出
摘要 我国急性肾损伤的发病率仍处于逐年上升趋势。急性肾损伤是临床工作中常见的危重症疾病,近些年来,随着其发病率、死亡率的不断增加,患者的经济负担不断加重,其收到重视的程度也在上升。白藜芦醇作为一种有抗炎、抗氧化、调节免疫等作用的中药,其在治疗急性肾损伤方面的研究仍相对较少,本文总结了白藜芦醇的药理作用,以及在肾损伤方面的研究进展。 The incidence of acute kidney injury in China is still increasing year by year. Acute kidney injury is a common critical disease in clinical work. In recent years, with the increasing incidence and mortality of acute kidney injury, the economic burden of patients is increasing, and the degree of attention received is also increasing. Resveratrol is a kind of traditional Chinese medicine with anti-inflammatory, antioxidant and immunomodulatory effects, and its research in the treatment of acute kidney injury is still relatively few. This paper summarizes the pharmacological effects of resveratrol and the research progress in kidney injury.
作者 钱一苇 刘雷
出处 《临床医学进展》 2022年第3期1509-1514,共6页 Advances in Clinical Medicine
  • 相关文献

参考文献7

二级参考文献130

共引文献236

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部